The analysis of LC3 expression in tumor and ANT tissues, in conjunction with an assessment of the presence of vascular tumor invasion and liver cirrhosis, could identify patients at risk of HCC recurrence after curative resection. Here, MAP1LC3A is linked to cirrhosis of liver.